If you didn't find what you were looking for, try a new search!
Basel, 9th July 2024. Medartis today announced that its Board has appointed Matthias Schupp to the position of CEO, joining Medartis by the beginning of November. Matthias will succeed Christoph Brönnimann, who will ensure a seamless transition. Matthias brings excellent knowledge [...]
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Medartis successfully places CHF 115.8 million [...]
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Basel, 17 March 2023: Medartis Holding AG (SIX: MED), an orthopaedic company specialising in head and extremity surgery, today announced the successful completion of a small capital increase of CHF 30 million in [...]
Basel, Switzerland, 3 May 2022 - Medartis Holding AG (SIX: MED) announced today that it has completed the acquisition of Nextremity Solutions Inc., a strategic commercialisation organisation located in Warsaw, USA. The total purchase price for the transaction will be up [...]
Medartis appoints Dirk Kirsten as Chief Financial Officer PRESS RELEASE Medartis appoints Dirk Kirsten as Chief Financial Officer Basel, Switzerland, 11 December 2020 – The Board of Directors of Medartis Holding AG (SIX:MED) has appointed Dirk Kirsten as new Chief [...]
Medartis nominates Marco Gadola for election to the Board of Directors Basel, Switzerland, 18. March 2020 – The Board of Directors of Medartis Holding AG (SIX: MED), a leading manufacturer and provider of medical devices for surgical fixation of bone [...]
Located in Basel, Switzerland, Medartis develops, manufactures and distributes medical internal fixation devices and surgical instruments offered in system solutions for small bone fractures focusing on the extremities. The company was founded in 1997 by Dr. Thomas Straumann and employs more [...]
Swiss medtech company Medartis is reportedly planning to expand into the U.S. market and continue investing in Germany with the funds from its recently-announced initial public offering. Medartis announced yesterday that its IPO could include up to 2.84 million new shares [...]
ZURICH, Feb 27 (Reuters) – Medartis Holding AG, a medical device maker specializing in surgical bone repairs, plans to sell shares in an initial public offering (IPO) on the SIX Swiss Exchange in the first half of 2018, it said on [...]
Endeavour Vision invested in Medartis. Located in Basel, Switzerland, the company develops, manufactures and distributes medical internal fixation devices and surgical instruments offered in system solutions for small bone fractures focusing on the extremities. Medartis was founded in 1997 by Dr. [...]